550.831 Contractual restrictions and limitations with pharmacists or pharmacies; disclosure of costs; payment at point of sale.
213 words·~1 min read·
/mi/chapter-550/550-831A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
550.831 Contractual restrictions and limitations with pharmacists or pharmacies; disclosure of costs; payment at point of sale.
Sec. 21.
(1)A contract between a pharmacy benefit manager and a pharmacist or a pharmacy that provides drug coverage for health plans must not prohibit or restrict a pharmacy or pharmacist from, or penalize a pharmacy or pharmacist for, disclosing to a covered person or enrollee health care information that the pharmacy or pharmacist considers appropriate regarding any of the following:
(a)The nature of the treatment or the risks or the alternatives to the treatment.
(b)The availability of alternate therapies, consultations, or tests.
(2)A pharmacy benefit manager shall not prohibit a pharmacy or pharmacist from discussing information regarding the total cost for pharmacist services for a drug or from selling a more affordable alternative to the covered person or enrollee if a more affordable alternative is available.
(3)A carrier, health plan, or pharmacy benefit manager shall not require a covered person or enrollee to make a payment for a prescription drug at the point of sale in an amount greater than the lesser of the following:
(a)The applicable copayment, coinsurance, and deductible.
(b)The final reimbursement amount to the network pharmacy.
History: 2022, Act 11 , Eff. Jan. 1, 2024